Search results :

Tapentadol

More information: STITCH, PubChem (stereo-specific compound: 1) and possibly Wikipedia

ATC Code: N02AX06

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8 9
Nausea 21% - 30% 7% - 13% x x x x x x x x x
Dizziness 17% - 24% 2% - 8% x x x x x x x x x
Somnolence 12% - 15% 1% - 4% x x x x x x x x x
Constipation 8% - 17% 1% - 7% x x x x x x x x x
Vomiting 8% - 18% 3% - 4% x x x x x x x x x
Fatigue 3% - 9% 1% - 4% x x x x x x x x x
Dry mouth 4% - 7% 1% - 2% x x x x x x x x x
Pruritus 5% - 8% 0% - 2% x x x x x x x x x
Insomnia 2% - 4% 1% - 3% x x x x x x x x x
Hyperhidrosis 3% - 5% 1% - 2% x x x x x x x x x
Anxiety 1% - 5% 1% - 4% x x x x x x x x x
Asthenia 2% 1% x x
Dyspepsia 1% - 3% 1% - 2% x x x x x x x x x
Irritability 2% 1% x x x x x x x x x
Lethargy 1% - 2% 0% - 1% x x x x x x x x x
Decreased appetite 2% - 6% 0% - 1% x x x x x x x x x
Pruritus generalised 1% - 3% 0% - 1% x x x x x x x x x
Hot flush 1% - 3% 1% - 2% x x x x x x x x x
Vertigo 1% - 2% 1% x x
Arthralgia 1% 1% x x x x x
Confusional state 1% 0% x x x x x x x x x
Depression 1% 1% x x
Dyspnoea 1% 0% x x x x x x x x x
Rash 1% 1% x x x x x x x x x
Hypoaesthesia 1% 1% x x x x x x x x x
Hypotension 1% 1% x x x x x x x x x
Nasopharyngitis 1% 1% x x x x x x x
Nervousness 1% 0% x x x x x x x x x
Tremor 1% - 3% 1% - 3% x x x x x x x x x
Upper respiratory tract infection 1% 1% x x x x x x x
Urinary tract infection 1% 1% x x x x x x x
Chills 1% 0% - 1% x x
Drug withdrawal syndrome 1% 1% x x x x x x x x x
Abdominal discomfort 1% 1% x x x x x x x x x
Disturbance in attention 1% 1% x x x x x x x x x
Abnormal dreams 1% - 2% 0% - 1% x x x x x x x x x
Erectile dysfunction 1% 1% x x
Vision blurred 1% 0% - 1% x x
Feeling hot 1% 1% x x x x x x x
Anaphylactic shock postmarketing x x x x
Angioedema postmarketing x x x x x x x
Mental disorder postmarketing x x x x x x x x x
Diarrhoea postmarketing, 7% 5% x x x x x x x
Gastrointestinal disorder postmarketing x x x x x x x x x
Hallucination postmarketing x x x x x x x x
Headache postmarketing, 10% - 15% 5% - 13% x x x x x x x x x
Cardiac disorder postmarketing x x x x x x x x x
Immune system disorder postmarketing x x x x x x x x x
Nervous system disorder postmarketing x x x x x x x x x
Palpitations postmarketing x x x x x
Panic attack postmarketing x x x
Suicidal ideation postmarketing x x x x
Ataxia x x x x x x x
Breast disorder x x
Infection x x x x x x x
Connective tissue disorder x x x x x x x
Cough x x x x x x x
Drug abuse x x x
Drug hypersensitivity x x
Dysarthria x x x x x x x x x
Oedema x x x x x x x
Eye disorder x x x x x x x x x
Hypersensitivity x x x x x x x
Bundle branch block left x x
Lung disorder x x x
Mediastinal disorder x x x x x x x x x
Nightmare x x
Paraesthesia x x x x x x x x x
Convulsion x x x x x x x x x
Withdrawal syndrome x
Syncope x x x x x x x x x
Tachycardia x x x x x x x x x
Pollakiuria x x x x x x x x x
Urinary tract disorder x x x x x x x x x
Urticaria x x x x x x x x x
Angiopathy x x x x x x x x x
Weight decreased x x
Agitation x x x x x x x x x
CNS depression NOS x x x x x
Gamma-glutamyltransferase increased x x x x x x x
Aspartate aminotransferase increased x x x x x x x
Alanine aminotransferase increased x x x x x x x
Urinary hesitation x x x x x x x x x
Malnutrition x x x x x x x x x
Unspecified disorder of skin and subcutaneous tissue x x x x x x x x x
Disorientation x x x x x x x x x
Thinking abnormal x x x x x x x x x
Perceptual disturbance x x
Memory impairment x x x x x x x x x
Respiratory depression x x x x x x x x x
Muscle contractions involuntary x x x x x x x
Euphoric mood x x x x x x x x x
Bradycardia x x x x x x x x x
Coordination abnormal x x x x x x x x x
Impaired gastric emptying x x x x x x x x x
Feeling drunk x x x x x x x x x
Visual disturbance x x x x x x x x x
Depressed level of consciousness x x x x x x x x x
Sexual dysfunction x x
Balance disorder x x
Sensation of heaviness x x x x x x x
Drug interaction x x x
Serotonin syndrome x x x x
Presyncope x x x x x x x x x
Oxygen saturation decreased x x x x x x x
Infestation NOS x x x x x x x
Hypotensive x x x x
Mental disability x x
Feeling abnormal x x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

tapentadol

Side effects:87
Source:FDA Structured Product Label

tapentadol

Side effects:88
Source:FDA Structured Product Label

tapentadol

Side effects:80
Source:FDA Structured Product Label

TAPENTADOL

Side effects:81
Source:FDA Structured Product Label

TAPENTADOL

Side effects:83
Source:FDA Structured Product Label

tapentadol

Side effects:83
Source:FDA Structured Product Label

TAPENTADOL

Side effects:84
Source:FDA Structured Product Label

tapentadol

Side effects:90
Source:FDA Structured Product Label

tapentadol

Side effects:90
Source:FDA Structured Product Label

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label